ANTONINI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 575
EU - Europa 129
AS - Asia 72
SA - Sud America 6
OC - Oceania 4
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 788
Nazione #
US - Stati Uniti d'America 569
SE - Svezia 43
IN - India 28
SG - Singapore 26
UA - Ucraina 26
DE - Germania 19
CN - Cina 17
FI - Finlandia 14
IT - Italia 13
AR - Argentina 6
AU - Australia 4
CA - Canada 4
GB - Regno Unito 4
IE - Irlanda 4
BG - Bulgaria 3
BE - Belgio 2
MX - Messico 2
AZ - Azerbaigian 1
EU - Europa 1
RO - Romania 1
TG - Togo 1
Totale 788
Città #
Fairfield 84
Woodbridge 78
Ann Arbor 46
Houston 44
Chandler 41
Ashburn 35
Seattle 33
Cambridge 19
Singapore 18
Wilmington 17
Princeton 16
Santa Clara 16
Boston 13
Plano 13
Beijing 12
Jacksonville 10
Dearborn 8
Fremont 8
Lawrence 8
Federal 6
San Diego 6
Falls Church 5
Bühl 4
Dublin 4
San Paolo di Civitate 4
Sydney 4
Andover 3
Millbury 3
Sofia 3
Boardman 2
Brussels 2
Casarile 2
Mannheim 2
Mexico City 2
Ottawa 2
Redmond 2
Rome 2
Toronto 2
Aiello Del Sabato 1
Anaheim 1
Auburn Hills 1
Baku 1
Berlin 1
Bremen 1
Des Moines 1
Guangdong 1
Guangzhou 1
Helsinki 1
Kunming 1
Leawood 1
Lomé 1
London 1
Nanchang 1
Norwalk 1
Pune 1
San Benedetto Ullano 1
San Francisco 1
San Mateo 1
Shanghai 1
Totale 600
Nome #
Efficacy and safety of simvastatin in long-term treatment of severe primary hypercholesterolemia 91
Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment 85
Serum lipoprotein pattern variations in dementia and ischemic stroke. 78
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia 76
Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease 74
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: Reduction during atorvastatin and fenofibrate therapy 68
Plasma cholesterol response to a change in dietary fat intake: A collaborative twin study 64
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: Results of a family and DNA-based screening 63
Plasma cholesterol levels in early onset multiple sclerosis 58
Identification of aminoethylcysteine ketimine decarboxylated dimer in human plasma 57
The common variants in the lipoprotein lipase (LPL) gene, but not those in the insulin receptor substrate-1 (IRS-1), the beta 3 adrenergic receptor (beta3AR) and the intestinal fatty acids binding protein-2 (FABP-2) genes influence the lipid phenotypic expression in familial combined hyperlipidemia 32
Efficacy and safety of atorvasatin vs.fenofibrate in familial combined hyperlipidemia (FCHL). A randomized, pilot, comparative study 30
THE EFFICACY AND SAFETY OF PRAVASTATIN AND SIMVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA 29
Totale 805
Categoria #
all - tutte 2.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 0 0 0 0 17 25 23 20 19 19 7 2
2020/202150 8 8 1 5 0 9 2 5 4 4 2 2
2021/2022152 1 10 16 6 16 8 3 18 14 12 21 27
2022/2023145 27 18 7 16 17 23 2 13 18 0 4 0
2023/202465 12 12 0 3 5 10 0 2 0 11 6 4
2024/202533 4 4 5 1 19 0 0 0 0 0 0 0
Totale 805